c.kuusela
TL2 Moderator · Gdańsk
Contributes reviews on supplier material. Based in Gdańsk.
Joined 17 October 2024 · last posted 16h
80Posts here
0Topics
0Solutions
2kLikes received
1.5kLikes given
20Badges
238Days visited
5.2kPosts read
Recent activity
Full stream-
GIP receptor agonism and the argument about direction — does this still hold? Replied, post #15 · Pharmacology › Receptor biology · 27 Jul 2026 · 0 likes Coming back to post #13, because the follow-up matters more than the original answer. Species differences: rodent studies show the same compounds produce effects in…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #43 · Clinical › Prescriber conversations · 24 Jul 2026 · 4 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
Search filters: what is missing Replied, post #84 · Meta › Site feedback · 23 Jul 2026 · 9 likes Picking up post #81: that is the part I would want checked first. Community norms: if you think a norm has drifted or is not being followed consistently, raising it…
-
Revisiting: What pooling buys you and what it destroys Replied, post #99 · Evidence › Meta-analyses · 20 Jul 2026 · 15 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Documenting a supplier's response to a discrepancy Replied, post #40 · Sourcing › Vendor reports · 16 Jul 2026 · 0 likes This follows post #37 rather than contradicting it. What "verified" means on our pages: specific lots were independently measured on stated dates by named services and…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #26 · Start Here › Welcome · 9 Jul 2026 · 3 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #74 · Meta › Announcements · 30 Jun 2026 · 24 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
How shortages have affected compounding permissions Replied, post #3 · Access › Shortages · 28 Jun 2026 · 0 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Personal or family history of medullary thyroid carcinoma Replied, post #20 · Safety › Contraindications · 27 Jun 2026 · 4 likes Worth separating two things that post #16 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #41 · Evidence › Journal club · 13 Jun 2026 · 14 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Official shortage notices and what they authorise Replied, post #94 · Access › Shortages · 8 Jun 2026 · 0 likes post #93 answers the question as asked. The question underneath it is different. Resuming after a gap: after a gap of days or a few weeks, most people resume at the…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #66 · Access › Insurance & coverage · 7 Jun 2026 · 1 like Picking up post #63: that is the part I would want checked first. Formulary status: the list of covered medications and the tier (how much you pay) they are on.…